Note: This document contains side effect information about hyoscyamine. Some of the dosage forms listed on this page may not apply to the brand name Oscimin.
Applies to hyoscyamine: oral conventional tablets and sublingual tablets, oral extended-release capsules and tablets, oral oral solution and elixir, oral orally disintegrating tablets, parenteral injection
Side effects include:
Most adverse effects are manifestations of pharmacologic effects at muscarinic-cholinergic receptors and usually are reversible when therapy is discontinued.
Severity and frequency of adverse effects are dose related and individual intolerance varies greatly; adverse effects occasionally may be obviated by a reduction in dosage but this also may eliminate potential therapeutic effects.
Adverse effects include dry mouth, urinary hesitancy and retention, blurred vision, tachycardia, palpitations, mydriasis, increased ocular tension, loss of taste, headache, nervousness, drowsiness, weakness, fatigue, dizziness, insomnia, nausea, vomiting, impotence, constipation, bloated feeling, abdominal pain, diarrhea, allergic reactions or drug idiosyncrasies, urticaria and other dermal manifestations, ataxia, speech disturbance, mental confusion and/or excitement (especially in geriatric patients), short-term memory loss, hallucinations, and decreased sweating.
Applies to hyoscyamine: compounding powder, injectable solution, oral capsule extended release, oral liquid, oral solution, oral spray, oral tablet, oral tablet chewable, oral tablet disintegrating, oral tablet extended release, sublingual tablet
Frequency not reported: Tachycardia, palpitations
Frequency not reported: Dryness of the mouth, nausea, vomiting, constipation, bloated feeling, abdominal pain, diarrhea
Frequency not reported: Urinary hesitancy and retention, impotence
Frequency not reported: Allergic reactions or drug idiosyncrasies
Frequency not reported: Loss of taste, headache, drowsiness, dizziness, ataxia, speech disturbance, some degree of mental confusion and/or excitement (especially in elderly persons), short-term memory loss
Frequency not reported: Blurred vision, mydriasis, increased ocular tension
Frequency not reported: Nervousness, insomnia, hallucinations
Frequency not reported: Weakness, fatigue
Frequency not reported: Urticaria and other dermal manifestations, decreased sweating
Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.
Source: Drugs.com Oscimin